Medivir selects Certara's D360 technology for drug discovery - Pharmaceutical Business Review

28-01-2014 Pharmaceutical Business ReviewComments (0)


The platform will be used by Medivir to deliver research data and analytic tools to its discovery chemists and biologists in Stockholm, Sweden, and Cambridge, UK, while the information will be sourced from its existing repository of chemical structure ...

Read more on Pharmaceutical Business Review

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top